Indian IT and pharma stocks are not benefiting from a weaker rupee as expected. Tariff concerns are overshadowing currency gains. Investors are waiting for clarity on trade deals. Foreign investors have also been selling these stocks. Valuations remain a concern for pharma companies. Demand for IT services shows signs of improvement. Stock selection will be crucial for investors.
Two suppliers provided dried milk powder that could be a culprit in the outbreak of botulism tied to ByHeart infant formula that has sickened dozens of babies.
A century-old, family-owned Chicago candy manufacturer filed for Chapter 11 bankruptcy protection Tuesday, seeking to keep its Northwest Side factory churning out assorted fruit-flavored starlights, lemonade drops and buttery toffee.
